Pain Self-Efficacy Emerges as a Key Link in Endometriosis Quality of Life
Endometriosis is often framed as a disease of lesions, staging, and pain scores. This study pushes the clinical conversation a step closer to the patient’s lived reality: how a woman interprets her illness and how confident she feels managing pain both track with health-related quality of life.
In a cross-sectional cohort of 300 women diagnosed with endometriosis, negative illness perceptions aligned with worse quality of life, while stronger pain self-efficacy aligned with better functioning. The association was not merely statistical background noise. Pain self-efficacy carried the stronger independent relationship with quality of life in regression analysis, and it partially mediated the connection between illness perceptions and HRQoL.
Symptom Burden Was High, and So Was Functional Strain
The cohort’s mean age was 30.0 ± 5.5 years. Most participants were married and held a bachelor’s degree, and two-thirds were overweight or obese. Stage III disease was present in 28.7% of the sample, and more than 80% reported moderate-to-severe pelvic pain. Those clinical details matter because they set the tone for the entire analysis: this was not a mildly affected group, but one carrying substantial symptom burden and daily impairment.
Illness perceptions and pain self-efficacy both sat at moderate levels, yet the quality-of-life signal was already markedly depressed, especially in the pain and emotional domains of the Endometriosis Health Profile-30. The pattern fits a familiar bedside observation. Two women can report similar lesion stages or pain intensity, but the one who expects helplessness from the disease often fares worse in work, relationships, and day-to-day coping.
A Psychological Pathway That Runs Through Pain Control
The study used the Brief Illness Perception Questionnaire, the Pain Self-Efficacy Questionnaire, and the Endometriosis Health Profile-30, then analyzed the data with SPSS version 27 and SmartPLS 4.0. Partial Least Squares Structural Equation Modeling with 5,000 bootstrap resamples tested both direct and mediating effects. Statistical significance was set at p < .05.
Negative illness perceptions were associated with worse HRQoL (r = 0.458, p < .001) and lower pain self-efficacy (r = −0.474, p < .001). Higher pain self-efficacy tracked with better quality of life (r = −0.542, p < .001). Those correlations suggest a coherent behavioral pathway: when a patient views endometriosis as more threatening, uncontrollable, or enduring, pain can become less manageable psychologically, and that loss of control can widen the gap between symptom burden and functioning.
Pain self-efficacy likely matters because it sits at the intersection of expectation, coping, and day-to-day behavior. Patients who believe they can still move, work, rest, and adapt despite chronic pelvic pain are more likely to use active coping strategies and less likely to spiral into avoidance. In chronic pain syndromes, this kind of self-belief often determines whether symptoms remain symptoms or become disability.
Variance Explained, But Not the Whole Story
Together, illness perceptions and pain self-efficacy explained 34.6% of the variance in quality of life. The stronger independent association belonged to pain self-efficacy, which places coping confidence closer to the center of the clinical picture than simple symptom appraisal alone.
The mediation analysis adds an important layer. Illness perceptions did not act only through a direct psychological burden; they also worked through pain self-efficacy. In practical terms, how a woman understands her disease appears to influence how capable she feels in handling pain, and that sense of capability then shapes quality of life. The pathway is plausible and clinically recognizable. A woman who interprets endometriosis as uncontrollable may begin to anticipate failure, reduce activity, and withdraw from normal roles, while a woman with stronger self-efficacy may preserve function even with persistent symptoms.
This is not an argument to minimize the biological reality of endometriosis. The lesion burden, inflammatory activity, pelvic pain, and associated distress remain central. But the study shows that symptom severity alone does not define the patient experience. Cognitive appraisal and coping confidence sit alongside pathology in determining daily outcome.
Why the Findings Matter in Routine Endometriosis Care
The cohort’s profile also suggests where clinical attention may be most useful. With substantial pain, frequent excess weight, and clear quality-of-life impairment, these women likely need more than procedural or hormonal symptom control. The data support a broader assessment that includes how patients conceptualize their disease and how confident they are in managing pain flares, activity limitations, and emotional strain.
In a practical clinic setting, that could mean asking direct questions about perceived control, treatment expectations, and the patient’s sense of competence when pain worsens. Those conversations are not peripheral. They may identify the patients most likely to benefit from education, counseling, and multidisciplinary pain support alongside gynecologic treatment.
The findings also fit the broader architecture of chronic pelvic pain. Endometriosis often behaves like a condition where nociception, central sensitization, emotional response, and coping style reinforce one another. When that loop tightens, quality of life falls even if the anatomic disease stage does not fully explain the functional loss. Pain self-efficacy may be one of the few modifiable points in that loop.
Cross-Sectional Data Point to Association, Not Causation
The design leaves a hard boundary in place. Cross-sectional measurements cannot establish whether negative illness perceptions reduce quality of life first, whether poor quality of life worsens illness perceptions, or whether both evolve together over time. The study also captures a single moment in a chronic disease that often fluctuates with treatment, menstrual cycling, and psychosocial stress.
Even so, the direction of the associations is clinically coherent and statistically consistent. The sample was large enough to detect meaningful relationships, and the mediation model offers a structured explanation for how cognition and confidence may interact in endometriosis. The next step is not another abstract description of burden. It is longitudinal work that tests whether changing illness perceptions or strengthening pain self-efficacy improves patient-reported outcomes over time.
Until then, this study leaves clinicians with a clear message grounded in the data: in endometriosis, pain is not the only variable worth treating. The way patients understand the disease, and how capable they feel of living with it, can shape quality of life as much as the pelvic pain itself.